50 results on '"Anampa, Jesus"'
Search Results
2. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
3. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer
4. Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer
5. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer
6. Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors
7. Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy
8. HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America
9. Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
10. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer
11. Human Immunodeficiency Virus (HIV) Infection and Cancer
12. Contributors
13. Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer
14. Anthracycline Use for Early Stage Breast Cancer in the Modern Era: a Review
15. Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement
16. The landscape of systemic therapy for early stage triple-negative breast cancer
17. Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer
18. Abstract P3-12-26: Baseline characteristics and survival of neuroendocrine carcinoma of the breast- A SEER database analysis
19. Racial Disparities in Neutrophil Counts Among Patients with Metastatic Breast Cancer during Treatment with CDK4/6 Inhibitors
20. Pregnancy-Associated Autoimmune Hemolytic Anemia: Meta-Analysis of Clinical Characteristics, Maternal and Neonatal Outcomes
21. Unusual cause of cholestatic jaundice in a patient with AIDS
22. Abstract PS4-30: Neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio as prognostic biomarkers in patients with metastatic breast cancer treated with CDK4/6 inhibitors
23. 62 - Human Immunodeficiency Virus (HIV) Infection and Cancer
24. Abstract P3-08-24: Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors
25. Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature
26. Applying the Hippocratic Oath in breast cancer-The case for promoting prevention
27. Abstract CT021: Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel (P) or eribulin (E) in patients with HER2 negative metastatic breast cancer (MBC)
28. Abstract 67: Chemotherapy induced pro-metastatic changes in the primary breast tumors of racially diverse patients
29. Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia
30. Colaboradores
31. 62 - Infección por el virus de la inmunodeficiencia humana (VIH) y cáncer
32. Dual Inhibition of Mdmx and Mdm2 Using an Alpha-Helical P53 Stapled Peptide (ALRN-6924) As a Novel Therapeutic Strategy in Acute Myeloid Leukemia
33. Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer
34. New agents for the management of resistant metastatic breast cancer
35. Dual inhibition of HDMX and HDM2 in acute myeloid leukemia
36. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
37. Abstract CT040: Phase Ib study of rebastinib plus antitubulin therapy with paclitaxel or eribulin in patients with metastatic breast cancer
38. Abstract 3963: Neoadjuvant chemotherapy promotes prometastatic changes in the primary breast tumor microenvironment in mice and humans
39. Breast cancer in patients with Li–Fraumeni syndrome – a case-series study and review of literature
40. Tailoring Adjuvant Therapy for Breast Cancer in the Elderly: Room for Improvement
41. Abstract 244: Paclitaxel increases the assembly and function of the tumor microenvironment of metastasis in breast cancer
42. Progress in adjuvant chemotherapy for breast cancer: an overview
43. Enhancing evaluation of cancer cachexia (CC) and sarcopenia through skeletal muscle mass (SMM) determination in patients (pts) with non-small cell lung cancer (NSCLC), assessing at the L1 level on routine chest CT: A prospective study of accuracy for cancer patients.
44. First Report of Reversible Macrocytic Anemia with Dysplastic Features Associated with Palbociclib Use in Patients with Metastatic Breast Cancer
45. The Evolving Adjuvant Treatment Landscape in Patients with Early Breast Cancer
46. Unusual cause of cholestatic jaundice in a patient with AIDS.
47. Treatment and Survival Differences between Patients with Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma of the Breast.
48. Phase Ib clinical and pharmacodynamic study of the TIE2 kinase inhibitor rebastinib with paclitaxel or eribulin in HER2-negative metastatic breast cancer.
49. Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer.
50. Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.